|
|
|
|
Telmisartan improves endothelial dysfunction and renal autoregulation in Dahl salt-sensitive rats
Hypertension Research 33, 135 (February 2010).doi:10.1038/hr.2009. Telmisartan improves endothelial dysfunction and renal autoregulation in Dahl salt-sensitive rats.
|
|
|
Micardis approved to reduce cardiovascular risk
ngelheim wish to announce that the European Commission has approved Micardis (telmisartan) for the reduction of cardiovascular morbidity in patients with: I.manifest atherothrombotic cardiovascular disease (history of coronary heart disease, stroke, or...
|
|
|
New Research Report: Malaysia Pharmaceuticals & Healthcare Report Q1 2010
In BMI's Business Environment Rating (BER) matrix for Q409, Malaysia considerably improved its position in the Asia Pacific matrix, and is now ranked fifth out of the 15 key regional markets.Key attractions of the Malaysian pharmaceutical market are the...
|
|
|
Effects of telmisartan on office- and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care
Kontny F et al.In this observational study, telmisartan 40 to 80 mg, or the fixeddose combination telmisartan 80 mg/HCT 12.5 mg, significantly increased the number of patients reaching target BP 140/90 mmHg if treatment nave or previously...
|
|
|
Blood pressure drugs cut dementia risk: study
MILLIONS of people taking drugs to reduce their blood pressure are halving their risk of developing Alzheimer's and dementia, research shows.A team of US researchers who examined the incidence of dementia among more than 800,000 people over four years found...
|
|
|
Blood pressure drugs cut dementia risk: study
MILLIONS of people taking drugs to reduce their blood pressure are halving their risk of developing Alzheimer's and dementia, research shows.A team of US researchers who examined the incidence of dementia among more than 800,000 people over four years found...
|
|
|
Blood pressure drugs cut dementia risk: study
MILLIONS of people taking drugs to reduce their blood pressure are halving their risk of developing Alzheimer's and dementia, research shows.A team of US researchers who examined the incidence of dementia among more than 800,000 people over four years found...
|
|
|
Blood pressure drugs cut dementia risk: study
MILLIONS of people taking drugs to reduce their blood pressure are halving their risk of developing Alzheimer's and dementia, research shows.A team of US researchers who examined the incidence of dementia among more than 800,000 people over four years found...
|
|
|
Report: Combo hypertension drugs could provide lower doses, be safer
FURTHER READING Company Decision Resources Novartis Person Nikhil Mehta Product amlodipine Diovan Micardis Norvasc Tareg telmisartan Topic angiotensin II receptor antagonist calcium channel blocker hypertension Pharmaceutical telmisartan Portals...
|
|
|
A Hypertension Drug Requiring Less-Frequent Dosing Than Novartis's Diovan/Tareg Would Earn Similar Patient Sha
WALTHAM, Mass., Jan.7 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a hypertension drug that requires less-frequent dosing than Novartis's Diovan/Tareg ...
|
|
|
Fixed-dose combo of telmisartan/amlodipine 'will become clinical gold standard for hypertension' in 2013
Keywords: Hypertension, Telmisartan, Amlodipine, Valsartan, Novartis, Market, USA, Europe, Fixed-dose combinations Related Articles 20 August 2009 10 August 2009 11 August 2009 16 December 2009 Recent Articles 8 January 2010 8 January 2010 8 January 2010...
|
|
|
A Hypertension Drug Requiring Less-Frequent Dosing Than Novartis's Diovan/Tareg Would Earn Similar Patient Share in Europe and U.S.
WALTHAM, Mass., Jan.7 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a hypertension drug that requires less-frequent dosing than Novartis's Diovan/Tareg ...
|
|
|
A Hypertension Drug Requiring Less-Frequent Dosing Than Novartis's Diovan/Tareg Would Earn Similar Patient Sha
The Fixed-Dose Combination Telmisartan/Amlodipine Will Become the New Decision Resources Clinical Gold Standard for Hypertension in 2013 PR Newswire WALTHAM, Mass., Jan.7 WALTHAM, Mass., Jan. 7 /PRNewswire/ -- Decision Resources, one of the world's leading...
|
|
|
A Hypertension Drug Requiring Less-Frequent Dosing Than Novartis's Diovan/Tareg Would Earn Similar P
WALTHAM, Mass., Jan.7 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a hypertension drug that requires less-frequent dosing than Novartis's Diovan/Tareg ...
|
|
|
A Hypertension Drug Requiring Less-Frequent Dosing Than Novartis's Diovan/Tareg Would Earn Similar Patient Share in Europe and U.S.
The Fixed-Dose Combination Telmisartan/Amlodipine Will Become the New Decision Resources Clinical Gold Standard for Hypertension in 2013 WALTHAM, Mass., Jan.7 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for...
|
|
|
A Hypertension Drug Requiring Less-Frequent Dosing Than Novartis's Diovan/Tareg Would Earn Similar Patient Sha
The Fixed-Dose Combination Telmisartan/Amlodipine Will Become the New Decision Resources Clinical Gold Standard for Hypertension in 2013 PR Newswire WALTHAM, Mass., Jan.7 WALTHAM, Mass., Jan. 7 /PRNewswire/ -- Decision Resources, one of the world's leading...
|
|
|
Treatment with telmisartan attenuates graft arteriosclerosis in murine cardiac allografts - Corrected Proof
Background: Chronic rejection remains the most prominent cause of graft failure after transplantation.Recently, it was reported that telmisartan can function as a partial agonist of peroxisome proliferator-activated receptor (PPAR) in addition to a...
|
|
|
Committee For Medicinal Products For Human Use Summary Of Positive Opinion For Telmisartan Teva
International Nonproprietary Name (INN): telmisartan LONDON, Nov.19, 2009-On 19 November 2009 the Committee for Medicinal Products for Human Use (CHMP), having considered new information, adopted a positive opinion, recommending to grant a marketing...
|
